feed,title,long_url,short_url
Benzinga,D.R. Horton Inc. Climbs to Annual-High Share Price,https://benzinga.com/news/earnings/21/12/24576347/d-r-horton-inc-climbs-to-annual-high-share-price,https://j.mp/3oMGBFs
Benzinga,Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation,https://benzinga.com/general/biotech/21/12/24575725/viracta-therapeutics-posts-data-from-lymphoma-trial-at-ash-presentation,https://j.mp/3m1UQ7A
Benzinga,Barclays Sees Sharp Upside In Archer-Daniels-Midland,https://benzinga.com/news/21/12/24573733/barclays-sees-sharp-upside-in-archer-daniels-midland,https://j.mp/3s3hmAU
Benzinga,"JPMorgan Upgrades Coca-Cola, Says Tax Dispute Ruling Could Be Next Catalyst",https://benzinga.com/analyst-ratings/analyst-color/21/12/24575671/jpmorgan-upgrades-coca-cola-says-tax-dispute-ruling-could-be-next-catalyst,https://j.mp/3EVpIy6
Benzinga,Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients,https://benzinga.com/general/biotech/21/12/24573016/comparing-data-sanofi-vs-johnson-johnson-multiple-myeloma-therapies-in-newly-diagnosed-patients,https://j.mp/3oRj9H4
Benzinga,Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet,https://benzinga.com/general/biotech/21/12/24575218/harpoon-shares-jump-after-early-data-from-bcma-targeting-myeloma-candidate-at-ash-meet,https://j.mp/3ykt2jP
